Creo Medical Group PLC (LON:CREO) Insider Richard John Rees Acquires 98,000 Shares of Stock

Creo Medical Group PLC (LON:CREO) insider Richard John Rees acquired 98,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 24th. The stock was acquired at an average cost of GBX 20 ($0.26) per share, with a total value of £19,600 ($25,447.94).

Creo Medical Group Stock Down 1.2 %

Shares of Creo Medical Group stock opened at GBX 20 ($0.26) on Friday. Creo Medical Group PLC has a 1-year low of GBX 19.86 ($0.26) and a 1-year high of GBX 50 ($0.65). The company has a market capitalization of £72.36 million, a P/E ratio of -333.33 and a beta of 0.86. The business’s fifty day moving average price is GBX 26.08 and its two-hundred day moving average price is GBX 31.09. The company has a debt-to-equity ratio of 29.96, a current ratio of 3.24 and a quick ratio of 2.19.

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.